Form 4: UAMY Officer Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Jeffrey Fink, VP and General Manager BRZ of United States Antimony Corp, reported selling 10,833 shares of common stock under a Rule 10b5-1 plan.
Summary
- Jeffrey Fink, VP, General Manager BRZ of United States Antimony Corp (UAMY), reported two transactions involving the sale of common stock.
- On October 3, 2025, Fink disposed of 2,833 shares of common stock at a price of $8.16 per share.
- On the same date, Fink also disposed of 8,000 shares of common stock at a price of $8.12 per share.
- These transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Following these transactions, Fink directly beneficially owns 56,000 shares of UAMY common stock.
Sentiment
Score: 5
Explanation: The sale of shares by an insider, even if part of a pre-arranged 10b5-1 plan, generally carries a neutral to slightly negative sentiment as it reduces insider ownership. The pre-arranged nature mitigates the immediate negative interpretation but doesn't eliminate it entirely.
Positives
- The transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), which suggests the sales were pre-scheduled and not based on immediate, non-public information.
Negatives
- Jeffrey Fink, an officer, disposed of a total of 10,833 shares of common stock, reducing his direct beneficial ownership to 56,000 shares.
- Despite being part of a 10b5-1 plan, insider selling can still be perceived by some investors as a signal of reduced confidence or a desire to diversify holdings.
Risks
- Insider selling, even if planned, can sometimes signal potential future challenges or a lack of confidence, which could impact investor sentiment.
Future Outlook
No specific future outlook or guidance is provided in this insider transaction report.
Industry Context
This filing pertains to an individual insider's stock transactions and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may interpret the insider selling as a negative signal, potentially impacting stock price perception.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Date of reported stock transactions by Jeffrey Fink. |
Recommendation
holdAn officer's sale of 10,833 shares, while executed under a Rule 10b5-1 plan, still represents a reduction in insider ownership. This event alone does not provide sufficient grounds for a 'sell' recommendation, but it warrants a 'hold' as investors should monitor for further developments and assess the broader context of the company's performance and market conditions.
Keywords
United States Antimony Corp, UAMY, Jeffrey Fink, Insider Trading, Form 4, Stock Sale, Officer Transaction, 10b5-1 Plan, Antimony
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.